Cargando…

Influence of target dose heterogeneity on dose sparing of normal tissue in peripheral lung tumor stereotactic body radiation therapy

OBJECTIVE: To evaluate the influence of target dose heterogeneity on normal tissue dose sparing for peripheral lung tumor stereotactic body radiation therapy (SBRT). METHODS: Based on the volumetric-modulated arc therapy (VMAT) technique, three SBRT plans with homogeneous, moderate heterogeneous, an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Zhigong, Peng, Xingchen, Wang, Yan, Yang, Lianlian, He, Ling, Liu, Zheran, Wang, Jingjing, Mu, Xiaoli, Li, Ruidan, Xiao, Jianghong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404286/ https://www.ncbi.nlm.nih.gov/pubmed/34461954 http://dx.doi.org/10.1186/s13014-021-01891-6

Ejemplares similares

Treatment plan comparison of volumetric‐modulated arc therapy to intensity‐modulated radiotherapy in lung stereotactic body radiotherapy using either 6‐ or 10‐MV photon energies
por: Wei, Zhigong, et al.
Publicado: (2022)

The Development and Validation of a Nomogram Incorporating Clinical, Pathological, and Therapeutic Features to Predict Overall Survival in Patients With Penile Cancer: A SEER-Based Study
por: Li, Ruidan, et al.
Publicado: (2022)

Association between Statin Use and Survival in Cancer Patients with Brain Metastasis: Retrospective Analysis from the Chinese Population
por: Min, Yu, et al.
Publicado: (2022)

Association between inflammatory bowel disease and pancreatic cancer: results from the two-sample Mendelian randomization study
por: Min, Yu, et al.
Publicado: (2023)

Frailty trajectory predicts subsequent cognitive decline: A 26‐year population‐based longitudinal cohort study
por: Li, Ruidan, et al.
Publicado: (2023)

Hepatitis B virus infection: An insight into the clinical connection and molecular interaction between hepatitis B virus and host extrahepatic cancer risk
por: Min, Yu, et al.
Publicado: (2023)

CT-Only Radiotherapy: An Exploratory Study for Automatic Dose Prediction on Rectal Cancer Patients Via Deep Adversarial Network
por: Cui, Jiaqi, et al.
Publicado: (2022)

Assessing the role of lipid-lowering therapy on multi-cancer prevention: A mendelian randomization study
por: Min, Yu, et al.
Publicado: (2023)

Association between BMI trajectories in late-middle age and subsequent dementia risk in older age: a 26-year population-based cohort study
por: Qin, Zijian, et al.
Publicado: (2023)

Survival outcomes following treatment delays among patients with early-stage female cancers: a nationwide study
por: Min, Yu, et al.
Publicado: (2022)

GLI1 expression in pancreatic ductal adenocarcinoma correlates the clinical significance and prognosis: A meta-analysis
por: Li, Ruidan, et al.
Publicado: (2020)

The association between aspirin use and immune-related adverse events in specific cancer patients receiving ICIs therapy: analysis of the FAERS database
por: Yang, Huaju, et al.
Publicado: (2023)

Dosimetric evaluation of the impacts of different heterogeneity correction algorithms on target doses in stereotactic body radiation therapy for lung tumors
por: Narabayashi, Masaru, et al.
Publicado: (2012)

High versus low dose Stereotactic Body Radiation Therapy for hepatic metastases
por: Kok, Esther N.D., et al.
Publicado: (2019)

The Association of Radiation Dose With Overall Survival for Patients Treated With Prostate Stereotactic Body Radiation Therapy
por: Waters, Michael R, et al.
Publicado: (2023)

Effect of the normal liver mean dose on intrahepatic recurrence in patients with hepatocellular carcinoma after receiving liver stereotactic body radiation therapy
por: Wu, Qi-Qiao, et al.
Publicado: (2022)

Feasibility study of stereotactic body radiotherapy for peripheral lung tumors with a maximum dose of 100 Gy in five fractions and a heterogeneous dose distribution in the planning target volume
por: Takeda, Atsuya, et al.
Publicado: (2014)

Dose-Intensified Stereotactic Ablative Radiation for Localized Prostate Cancer
por: Chen, Lily, et al.
Publicado: (2022)

Differences in the dose–volume metrics with heterogeneity correction status and its influence on local control in stereotactic body radiation therapy for lung cancer
por: Ueki, Nami, et al.
Publicado: (2013)

Contribution of Imaging to Organs at Risk Dose during Lung Stereotactic Body Radiation Therapy
por: Savanović, Milovan, et al.
Publicado: (2021)

Making radiation therapy more effective in the era of precision medicine
por: Peng, Xingchen, et al.
Publicado: (2020)

Hepatic arterial phase and portal venous phase computed tomography for dose calculation of stereotactic body radiation therapy plans in liver cancer: a dosimetric comparison study
por: Xiao, Jianghong, et al.
Publicado: (2013)

Automated inverse optimization facilitates lower doses to normal tissue in pancreatic stereotactic body radiotherapy
por: Mihaylov, Ivaylo B., et al.
Publicado: (2018)

A Unified Dose Response Relationship to Predict High Dose Fractionation Response in the Lung Cancer Stereotactic Body Radiation Therapy
por: Kehwar, Than S., et al.
Publicado: (2017)

Effect of Target Changes on Target Coverage and Dose to the Normal Brain in Fractionated Stereotactic Radiation Therapy for Metastatic Brain Tumors
por: Miura, Hideharu, et al.
Publicado: (2023)

Dose tolerance limits and dose volume histogram evaluation for stereotactic body radiotherapy
por: Grimm, Jimm, et al.
Publicado: (2011)

Urethra-sparing stereotactic body radiotherapy for prostate cancer: how much can the rectal wall dose be reduced with or without an endorectal balloon?
por: Dubouloz, Angèle, et al.
Publicado: (2018)

A unified multi‐activation (UMA) model of cell survival curves over the entire dose range for calculating equivalent doses in stereotactic body radiation therapy (SBRT), high dose rate brachytherapy (HDRB), and stereotactic radiosurgery (SRS)
por: Li, Shidong, et al.
Publicado: (2021)

Is higher dose always the right answer in stereotactic body radiation therapy for small hepatocellular carcinoma?
por: Lee, Kyung Hwa, et al.
Publicado: (2018)

Influence of the Hypersensitivity to Low Dose Phenomenon on the Tumor Response to Hypofractionated Stereotactic Body Radiation Therapy
por: Le Reun, Eymeric, et al.
Publicado: (2023)

Dose escalation in the era of ablative lung irradiation: is more dose better when it comes to delivery of lung stereotactic body radiation therapy?
por: Alite, Fiori, et al.
Publicado: (2020)

Estimation of the effects of normal tissue sparing using equivalent uniform dose-based optimization
por: Senthilkumar, K., et al.
Publicado: (2016)

Safety of high-dose-rate stereotactic body radiotherapy
por: Stieb, Sonja, et al.
Publicado: (2015)

Rectal Radiation Dose and Clinical Outcomes in Prostate Cancer Patients Treated With Stereotactic Body Radiation Therapy With and Without Hydrogel
por: Kundu, Palak, et al.
Publicado: (2022)

Difference in dose‐volumetric data between the analytical anisotropic algorithm, the dose‐to‐medium, and the dose‐to‐water reporting modes of the Acuros XB for lung stereotactic body radiation therapy
por: Mampuya, Wambaka A., et al.
Publicado: (2016)

Threshold doses and prediction of visually apparent liver dysfunction after stereotactic body radiation therapy in cirrhotic and normal livers using magnetic resonance imaging
por: Doi, Hiroshi, et al.
Publicado: (2016)

Robotic Stereotactic Radiotherapy for Intracranial Meningiomas—An Opportunity for Radiation Dose De-Escalation
por: Grzbiela, Hanna, et al.
Publicado: (2023)

Stereotactic Body Radiation Therapy for Low- and Low-Intermediate-Risk Prostate Cancer: Is there a Dose Effect?
por: Katz, Alan J., et al.
Publicado: (2011)

Stereotactic body radiation therapy for hepatocellular carcinoma: Practice patterns, dose selection and factors impacting survival
por: Robbins, Jared R., et al.
Publicado: (2019)

A Dose Falloff Gradient Study in RapidArc Planning of Lung Stereotactic Body Radiation Therapy
por: Narayanasamy, Ganesh, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9jba57hp7aeauros3dag4coh3a